Trials / Completed
CompletedNCT02650076
A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to confirm the target receptor occupancy of SK-1405 and to correlate receptor occupancy with SK-1405 dose and plasma concentration. The secondary objective is to assess the safety and tolerability of SK-1405 in healthy, Caucasian, male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SK-1405 |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-04-01
- First posted
- 2016-01-08
- Last updated
- 2016-04-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02650076. Inclusion in this directory is not an endorsement.